Skip to main content

Advertisement

Log in

Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635–48.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LAB, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54–61.

    Article  PubMed  Google Scholar 

  3. Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131(6):1611–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Rutsch F, MacDougall M, Lu C, Buers I, Mamaeva O, Nitschke Y, et al. A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. Am J Hum Genet. 2015;96(2):275–82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Al Shehri T, Abinun M, Gennery AR, et al. Is gain-of-function STAT1 CMC an interferonopathy? Clin Exp Immunol. 2015;182(S1):15.

    Google Scholar 

  7. Higgins E, Al Shehri T, McAleer MA, et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J Allergy Clin Immunol. 2015;135(2):551–3.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge the assistance of our colleagues in the Northern Molecular Genetics Service in Newcastle-upon-Tyne and the advice of Drs Anne Puel, Yannick Crow, and J.L Casanova. Finally, we wish to acknowledge the goodwill of the patient and her family.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna E. Smyth.

Ethics declarations

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smyth, A.E., Kaleviste, E., Snow, A. et al. Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation. J Clin Immunol 38, 468–470 (2018). https://doi.org/10.1007/s10875-018-0513-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-018-0513-z

Navigation